Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

BUY
$233.08 - $265.59 $11,420 - $13,013
49 Added 1225.0%
53 $13,000
Q2 2023

Aug 03, 2023

SELL
$224.99 - $256.14 $4,499 - $5,122
-20 Reduced 83.33%
4 $0
Q1 2023

May 01, 2023

BUY
$239.75 - $277.0 $4,795 - $5,540
20 Added 500.0%
24 $6,000
Q4 2022

Feb 06, 2023

BUY
$241.42 - $282.29 $965 - $1,129
4 New
4 $1,000
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $3.58 Million - $4.39 Million
-13,910 Closed
0 $0
Q4 2021

Jan 26, 2022

BUY
$292.08 - $329.01 $163,564 - $184,245
560 Added 4.19%
13,910 $4.58 Million
Q3 2021

Nov 08, 2021

BUY
$272.21 - $332.43 $136,105 - $166,215
500 Added 3.89%
13,350 $4.06 Million
Q2 2021

Jul 28, 2021

BUY
$225.08 - $271.69 $2.89 Million - $3.49 Million
12,850 New
12,850 $3.45 Million
Q1 2020

May 08, 2020

SELL
$121.39 - $169.05 $31,561 - $43,953
-260 Closed
0 $0
Q4 2019

Jan 10, 2020

BUY
$133.47 - $153.48 $34,702 - $39,904
260 New
260 $40,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.